Package Leaflet: Information for the Patient
Kyntheum210mg solution for injection in pre-filled syringe
brodalumab
Read all of this leaflet carefully before you start using this medicine because it contains important information for you.
Contents of the pack
Kyntheum contains the active substance brodalumab. Brodalumab is a monoclonal antibody, a distinct type of protein that recognizes and binds to certain proteins in the body.
Brodalumab belongs to a group of medicines known as interleukin inhibitors (IL). This medicine blocks the activity of IL-17 proteins, which are present in high levels in diseases such as psoriasis.
Kyntheum is used to treat a skin disease called "plaque psoriasis", which causes skin inflammation and the formation of scaly plaques. Kyntheum is indicated in adults with moderate to severe plaque psoriasis with extensive body surface area involvement.
Using Kyntheum will help improve skin clearance and reduce the signs and symptoms of psoriasis, such as itching, redness, scaling, burning, stinging, cracking, flaking, and pain.
Do not use Kyntheum
Warnings and precautions
Consult your doctor, pharmacist, or nurse before starting treatment with Kyntheum:
After starting treatment with Kyntheum, inform your doctor, pharmacist, or nurse immediately:
Inflammatory bowel disease (Crohn's disease or ulcerative colitis)
Stop taking Kyntheum and inform your doctor or seek medical attention immediately if you notice abdominal pain and cramps, diarrhea, weight loss, or blood in your stool (any sign of intestinal problems).
Monitor for allergic reactions
Kyntheum may potentially cause serious side effects, including allergic reactions. You should monitor for these signs and symptoms while using Kyntheum.
Interrupt treatment with Kyntheum and inform your doctor or seek medical attention immediately if you notice any signs of a possible allergic reaction. These signs are listed in section 4 "Serious side effects".
Children and adolescents
Kyntheum is not recommended for children and adolescents (under 18 years), as it has not been studied in this age group.
Other medicines and Kyntheum
Inform your doctor or pharmacist:
Pregnancy and breastfeeding
If you are pregnant or breastfeeding, think you may be pregnant, or are planning to have a baby, ask your doctor or pharmacist for advice before taking this medicine. Kyntheum has not been studied in pregnant women, and it is not known whether this medicine could harm the fetus. Therefore, it is recommended to avoid using Kyntheum during pregnancy. If you are a woman of childbearing age, you are advised to avoid becoming pregnant and should use adequate contraception while using Kyntheum and for at least 12 weeks after the last dose of Kyntheum.
It is not known whether brodalumab passes into breast milk. If you are breastfeeding or plan to breastfeed, consult your doctor. Your doctor will help you decide whether to stop breastfeeding or stop using Kyntheum, weighing the benefits of breastfeeding for the baby and the benefits of Kyntheum for you.
Driving and using machines
Kyntheum is unlikely to affect your ability to drive or use machines.
Kyntheum should only be prescribed by a doctor with experience in the diagnosis and treatment of psoriasis.
Follow the instructions for administration of this medicine exactly as your doctor, pharmacist, or nurse has told you. If you are unsure, consult your doctor, pharmacist, or nurse again.
How much Kyntheum to use
How to use Kyntheum
Kyntheum is given by injection under the skin (subcutaneous injection).
Instructions for self-administration
Read the detailed "Instructions for use" provided with this medicine to learn how to store, prepare, and administer the injections correctly at home.
If you use more Kyntheum than you should
Inform your doctor if you use more medicine than prescribed or if you have administered the dose earlier than scheduled.
If you forget to use Kyntheum
If you miss a dose of Kyntheum, inject the next dose as soon as possible after the missed dose. Then, ask your doctor when to inject the next dose. Do not administer a double dose to make up for the missed doses.
If you stop using Kyntheum
Do not stop using Kyntheum without talking to your doctor first. If you stop treatment, the symptoms of psoriasis may return.
If you have any further questions on the use of this medicine, ask your doctor, pharmacist, or nurse.
Like all medicines, this medicine can cause side effects, although not everybody gets them.
Serious side effects
Stop treatment with Kyntheum and inform your doctor or seek medical attention immediately if you notice any of the following side effects. Your doctor will decide whether you should and when you can restart treatment.
Severe allergic reaction(may affect up to 1 in 1,000 people); symptoms may include:
Serious infections(may affect up to 1 in 100 people); symptoms may include:
Other side effects
Common (may affect up to 1 in 10 people)
Uncommon (may affect up to 1 in 100 people)
Most of these side effects are mild to moderate. If any of these side effects gets serious, inform your doctor, pharmacist, or nurse.
Abdominal pain and cramps, diarrhea, weight loss, or blood in the stool (signs of intestinal problems) have also been reported with IL-17 inhibitors like Kyntheum.
Reporting of side effects
If you experience any side effects, talk to your doctor, pharmacist, or nurse, even if they are not listed in this leaflet. You can also report side effects directly via the national reporting system listed in Appendix V. By reporting side effects, you can help provide more information on the safety of this medicine.
Keep this medicine out of the sight and reach of children.
Do not use this medicine after the expiry date which is stated on the outer packaging and on the label of the pre-filled syringe after EXP. The expiry date is the last day of the month stated.
Store the pre-filled syringe in the outer packaging to protect it from light.
Store in a refrigerator (between 2°C and 8°C). Do not freeze.
Kyntheum can be stored at room temperature up to 25°C in the outer packaging for 14 days. Discard Kyntheum if not used within 14 days of storage at room temperature.
Do not use this medicine if you notice that the solution is cloudy, has lost color, or contains particles, flakes, or precipitates.
Medicines should not be disposed of via wastewater or household waste. Ask your pharmacist how to dispose of medicines no longer required. This will help protect the environment.
Kyntheum Composition
Product Appearance and Container Contents
Kyntheum is a clear or slightly opalescent, colorless or slightly yellowish injectable solution that does not contain particles.
Kyntheum is available in single-unit containers of 2 pre-filled syringes and in multiple-unit containers that contain 3 boxes, each with 2 pre-filled syringes. Not all pack sizes may be marketed.
Marketing Authorization Holder
LEO Pharma A/S
Industriparken 55
DK-2750 Ballerup
Denmark
Manufacturer
Laboratoires LEO
39 route de Chartres
28500 Vernouillet
France
LEO Pharma A/S
Industriparken 55
DK-2750 Ballerup
Denmark
You can request more information about this medication by contacting the local representative of the marketing authorization holder:
Belgium/Belgique/Belgien LEO Pharma N.V./S.A Tel: +32 3 740 7868 | Lithuania LEO Pharma A/S Tel: +45 44 94 58 88 |
Bulgaria Borola Ltd Tel: +359 2 9156 136 | Luxembourg/Luxemburg LEO Pharma N.V./S.A Tel: +32 3 740 7868 |
Czech Republic LEO Pharma s.r.o. Tel: +420 225 992 272 | Hungary LEO Pharma Tel: +36 1 888 0525 |
Denmark LEO Pharma AB Tel: +45 70 22 49 11 | Malta E.J. Busuttil Ltd Tel: +356 2144 7184 |
Germany LEO Pharma GmbH Tel: +49 6102 2010 | Netherlands LEO Pharma B.V. Tel: +31 205104141 |
Estonia LEO Pharma A/S Tel: +45 44 94 58 88 | Norway LEO Pharma AS Tel: +47 22514900 |
Greece LEO Pharmaceutical Hellas S.A. Tel: +30 210 68 34322 | Austria LEO Pharma GmbH Tel: +43 1 503 6979 |
Spain Laboratorios LEO Pharma, S.A. Tel: +34 93 221 3366 | Poland LEO Pharma Sp. z o.o. Tel: +48 22 244 18 40 |
France LEO Pharma Tel: +33 1 3014 4000 | Portugal LEO Farmacêuticos Lda. Tel: +351 21 711 0760 |
Croatia Remedia d.o.o Tel: +385 1 3778 770 | Romania LEO Pharma Romania Tel: +40 213121963 |
Ireland LEO Laboratories Ltd Tel: +353 (0) 1 490 8924 | Slovenia PHARMAGAN d.o.o. Tel: +386 4 2366 700 |
Iceland Vistor hf. Tel: +354 535 7000 | Slovakia LEO Pharma s.r.o. Tel: +421 2 5939 6236 |
Italy LEO Pharma S.p.A Tel: +39 06 52625500 | Finland LEO Pharma Oy Tel: +358 20 721 8440 |
Cyprus The Star Medicines Importers Co. Ltd. Tel: +357 2537 1056 | Sweden LEO Pharma AB Tel: +46 40 3522 00 |
Latvia LEO Pharma A/S Tel: +45 44 94 58 88 | United Kingdom(Northern Ireland) LEO Laboratories Ltd Tel: +44 (0) 1844 347333 |
Date of Last Revision of this Leaflet:
Other Sources of Information
Detailed information on this medicinal product is available on the European Medicines Agency website: http://www.ema.europa.eu.
Instructions for Use:
Kyntheum (brodalumab)
Injectable Solution in Pre-filled Syringe
Subcutaneous Administration
Kyntheum is presented in a single-use pre-filled syringe. Each syringe contains a dose of Kyntheum of 210 mg. Your doctor, pharmacist, or nurse will tell you how often to inject the medication. Each Kyntheum pre-filled syringe can only be used once.
If your doctor decides that you or a caregiver can administer the injections at home, you will be trained on how to prepare and inject Kyntheum correctly. Do not attempt to inject the medication until your doctor has instructed you on how to administer the injections correctly.
Read all the instructions before using the Kyntheum pre-filled syringe.Call your doctor, pharmacist, or nurse if you or your caregiver have any questions about how to inject Kyntheum correctly.
Important:The needle is inside
Important
Before using a Kyntheum pre-filled syringe,read the following instructions:
Storage of Kyntheum Pre-filled Syringes
Using Kyntheum Pre-filled Syringes
Step 1: Preparation
Hold the syringe by the cylinder to remove it from the tray.
If any syringes are left unused, store the box in the refrigerator.
For safety reasons:
Let the syringe sit at room temperature for at least 30minutes before injecting the medication.
Important:Always hold the pre-filled syringe by the cylinder.
Always hold the syringe by the cylinder.
Make sure the medication in the syringe is clear or slightly opalescent and colorless or slightly yellowish.
Wash your hands thoroughly with soap and water.
On a clean, well-lit work surface, place:
You or your caregiver can administer the injection in:
Only the caregiver can administer the injection in:
Step 2: Preparation for Injection
Discard the needle protector in the puncture-resistant container.
You may see small air bubbles in the syringe or a drop of liquid on the tip of the needle. Both are normal and do not need to be removed.
Hold the skin firmly with your thumb and other fingers and create an area about 5 cm wide.
Important:Continue to hold the skin until you have injected the medication.
Step 3: Injection
Do notplace your finger on the plunger while inserting the needle.
Important:If, when removing the syringe, you see that there is still medication in the syringe cylinder, the full dose has not been administered. Call your doctor, pharmacist, or nurse immediately.
Step 4: Completion
Important:Keep the puncture-resistant container out of sight and reach of children.
If there is bleeding, press the injection site with a cotton ball or gauze pad. Do notrub the injection site. Cover it with a band-aid if necessary.